TY - JOUR
KW - Collaboration
KW - Drug Costs
KW - Neglected tropical diseases (NTDs)
AU - Pollastri MP
AB - Some of the best practices in industrial drug discovery, which include careful compound design, streamlined synthesis, compound assessment via a well-defined testing cascade, plus informatics implementation to interpret the experimental results, are now being applied to NTD drug discovery. This environment has produced credible, early-stage drug discovery programs that are more likely to produce new therapies for NTDs in the coming years and fill the pipelines within product development partnerships.
BT - PLoS neglected tropical diseases
C1 - http://www.ncbi.nlm.nih.gov/pubmed/24992488?dopt=Abstract
DO - 10.1371/journal.pntd.0002866
IS - 7
J2 - PLoS Negl Trop Dis
LA - eng
N2 - Some of the best practices in industrial drug discovery, which include careful compound design, streamlined synthesis, compound assessment via a well-defined testing cascade, plus informatics implementation to interpret the experimental results, are now being applied to NTD drug discovery. This environment has produced credible, early-stage drug discovery programs that are more likely to produce new therapies for NTDs in the coming years and fill the pipelines within product development partnerships.
PY - 2014
EP - e2866
T2 - PLoS neglected tropical diseases
TI - Finding new collaboration models for enabling neglected tropical disease drug discovery.
UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081034/pdf/pntd.0002866.pdf
VL - 8
SN - 1935-2735
ER -